European union regulation of health technology assessment: what is required for it to succeed?

This publication has 10 references indexed in Scilit:

• Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
  The European Journal of Health Economics, 2021
• Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal
  International Journal of Technology Assessment in Health Care, 2021
• Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches
  Orphanet Journal of Rare Diseases, 2020
• Performance-based managed entry agreements for new medicines in OECD countries and EU member states
  2019
• Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy
  Value in Health, 2019
• Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward
  Value in Health, 2017
• Challenges in the Assessment of Medical Devices: The MedtecHTA Project
  Health Economics, 2017
• Cancer Drugs Fund requires further reform
  BMJ, 2016
• Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework
  Nature Reviews Drug Discovery, 2016
• Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
  Value in Health, 2011